1. Home
  2. HMN vs GENB Comparison

HMN vs GENB Comparison

Compare HMN & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horace Mann Educators Corporation

HMN

Horace Mann Educators Corporation

HOLD

Current Price

$54.94

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$16.82

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HMN
GENB
Founded
1945
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
HMN
GENB
Price
$54.94
$16.82
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$47.33
$23.20
AVG Volume (30 Days)
291.8K
1.0M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
3.05%
N/A
EPS Growth
57.26
N/A
EPS
1.00
N/A
Revenue
$1,701,400,000.00
N/A
Revenue This Year
$6.91
N/A
Revenue Next Year
$3.41
$16.58
P/E Ratio
$54.12
N/A
Revenue Growth
6.66
N/A
52 Week Low
$40.04
$11.00
52 Week High
$54.64
$18.18

Technical Indicators

Market Signals
Indicator
HMN
GENB
Relative Strength Index (RSI) 82.02 61.75
Support Level $41.94 $11.73
Resistance Level N/A N/A
Average True Range (ATR) 1.27 1.22
MACD 0.42 0.18
Stochastic Oscillator 91.80 73.50

Price Performance

Historical Comparison
HMN
GENB

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: